THIS boy was given a second chance at life by his sister, who fought through sepsis to help him survive. Three-year-old James Gillespie, the youngest of six children, was rushed to hospital on ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data from the BEACON Phase 1/2 ...
The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...